Anti-CGRP for Inflamation and Pain Modulation in Small Fiber Neuropathy/Fibromyalgia
Conditions: Trigeminal Neuralgia; Glossopharyngeal Neuralgia Intervention: Drug: Galcanezumab Sponsors: Duke University; Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials